Dr. Rachel Goodwin
Claim this profileUniversity of Ottawa / Ottawa General Hospital
Studies Colorectal Cancer
Studies Cancer
3 reported clinical trials
13 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
HER2 positive
Stage III
2Cancer
HER2 positive
Stage IV
KRAS negative
Affiliated Hospitals
Clinical Trials Rachel Goodwin is currently running
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting2 awards Phase 3
SGN-CEACAM5C
for Advanced Cancers
This trial is testing a new drug called SGN-CEACAM5C for patients with hard-to-treat solid tumors that have either returned or didn't respond to standard treatments. The drug targets cancer cells and kills them. The study will determine the safe dosage and effectiveness of the drug.
Recruiting1 award Phase 17 criteria
More about Rachel Goodwin
Clinical Trial Related7 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Rachel Goodwin has experience with
- Tucatinib
- Trastuzumab
- Fluorouracil
- Levoleucovorin
- Leucovorin
- Oxaliplatin
Breakdown of trials Rachel Goodwin has run
Colorectal Cancer
Adenocarcinoma
Pancreatic Cancer
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachel Goodwin specialize in?
Rachel Goodwin focuses on Colorectal Cancer and Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Rachel Goodwin currently recruiting for clinical trials?
Yes, Rachel Goodwin is currently recruiting for 2 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that Rachel Goodwin has studied deeply?
Yes, Rachel Goodwin has studied treatments such as Tucatinib, Trastuzumab, Fluorouracil.
What is the best way to schedule an appointment with Rachel Goodwin?
Apply for one of the trials that Rachel Goodwin is conducting.
What is the office address of Rachel Goodwin?
The office of Rachel Goodwin is located at: University of Ottawa / Ottawa General Hospital, Ottawa, Ontario K1H 8L6 Canada. This is the address for their practice at the University of Ottawa / Ottawa General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.